ALHAMBRA, Calif., Jan. 24,
2024 /PRNewswire/ -- Apollo Medical Holdings, Inc.
("ApolloMed," and together with its subsidiaries and affiliated
entities, the "Company") (NASDAQ: AMEH), a leading
provider-centric, technology-powered healthcare company which
enables providers to deliver accessible, high-quality, and
high-value care to all, today announced the following leadership
transitions:
- Brandon Sim, the company's Co-CEO, has been named
President and Chief Executive Officer, effective January 19, 2024.
- Dr. Thomas Lam will serve as
Vice Chairman of the Board of Directors and is retiring as
President and Co-CEO, effective January 19,
2024.
- Chan Basho remains Chief Financial Officer and, in
addition, has been named Chief Operating Officer, effective
January 19, 2024.
- Dr. Dinesh Kumar will be joining the executive team as
Chief Medical Officer of ApolloMed, effective January 23, 2024.
Dr. Lam, a co-founder of ApolloMed, led the Company in its
growth from a private, regional organization in Southern California into a publicly traded,
technology-powered integrated healthcare delivery platform
empowering over 10,000 providers across the country. As part of a
rigorously planned process, Mr. Sim will continue to lead ApolloMed
into its next chapter of growth as President and CEO, alongside Mr.
Basho, COO and CFO, and Dr. Kumar, CMO.
Dr. Thomas Lam, Vice Chairman of
the Board of Directors of ApolloMed, stated, "It has been an
honor to serve as President and Chief Executive Officer of
ApolloMed, and I am extremely proud of the high-access,
high-quality, and high-value healthcare we have brought to
communities across the country for decades. Over the past several
years, I have partnered with Brandon and witnessed the fresh
energy, technology-forward perspective, and high level of execution
that Brandon has imbued into the organization as we strive to
provide industry-leading care for all. I, along with the Board of
Directors, am confident that his innovative mindset, strategic
thinking, and demonstrated leadership ability make him the best
person to lead ApolloMed's success in its next chapter of growth as
a leading, national value-based healthcare platform."
Brandon Sim, President and Chief
Executive Officer of ApolloMed, said, "Both ApolloMed and I are
extremely grateful for the innumerable contributions that Dr. Lam
has made over the last several decades, not only to our Company but
to the entire healthcare industry. He is truly a visionary and
healthcare pioneer, and I am honored to have the opportunity to
continue leading ApolloMed as we accelerate our path towards our
mission to deliver exceptional care to communities across the
country. I am grateful to have had the chance to work so closely
with Dr. Lam over the past five years and look forward to
continuing to work with Dr. Lam in his new role as Vice Chairman of
the Board."
"I am also very excited to continue working with Chan in his new
role as COO. Chan has been instrumental in helping build and scale
ApolloMed to where we are today. His unwavering alignment with our
core values and his focus on strengthening our foundation for
growth makes him the perfect fit to lead our Company as Chief
Operating Officer," continued Mr. Sim.
"Last but not least, I am thrilled to partner with Dr.
Dinesh Kumar and welcome him to the
executive team as Chief Medical Officer. In his new role, Dr. Kumar
will lead medical and care management, quality, clinical delivery,
and health services teams and serve as a key executive team member.
Dr. Kumar brings deep clinical, provider, and payer experience to
our organization, as well as an incredible passion for growing the
impact that our unique care model is having on local communities.
His experience and leadership will support our efforts to scale our
proven care model across the country and continue our excellence in
driving quality and value for our members and partners," stated Mr.
Sim.
Dr. Dinesh Kumar, a visionary
healthcare leader with over 25 years of healthcare experience, has
spent his career transforming healthcare for the better, across
clinical, provider group, and payer settings. Prior to his
appointment as CMO of ApolloMed, Dr. Kumar served as Chief Medical
and Chief Operating Officer at Alignment Healthcare. Before that,
Dr. Kumar led value-based care and population health efforts as
Senior Vice President of Clinical Transformation at DaVita. Prior,
he served as Chief Medical Officer of HealthCare Partners within
the California market.
Dr. Kumar received his medical degree from the University of
Madras and completed his residency in internal medicine at
Howard University. He then completed
his fellowship in pulmonary and critical care medicine at
Harbor-UCLA Medical Center and completed a Health Care Leadership
Program at the University of California-San
Francisco.
About Apollo Medical Holdings, Inc.
ApolloMed is a leading provider-centric, technology-powered
healthcare company which enables providers to deliver accessible,
high-quality, and high-value care to all. Leveraging its
proprietary end-to-end technology solutions, ApolloMed operates an
integrated healthcare delivery platform that enables providers to
successfully participate in value-based care arrangements, thus
empowering them to deliver high quality care to patients in a
cost-effective manner.
Headquartered in Alhambra,
California, ApolloMed's subsidiaries and affiliates include
management services organizations (MSOs), affiliated independent
practice associations (IPAs), and entities participating in the
Centers for Medicare & Medicaid Services Innovation Center
(CMMI) innovation models. For more information, please
visit www.apollomed.net.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995, such as statements about the Company's prospects
Forward-looking statements reflect current views with respect to
future events and financial performance and therefore cannot be
guaranteed. Such statements are based on the current expectations
and certain assumptions of the Company's management, and some or
all of such expectations and assumptions may not materialize or may
vary significantly from actual results. Actual results may also
vary materially from forward-looking statements due to risks,
uncertainties and other factors, known and unknown, including the
risk factors described from time to time in the Company's reports
to the Securities and Exchange Commission, including, without
limitation, the risk factors discussed in the Company's Annual
Report on Form 10-K/A for the year ended December 31, 2022, and any subsequent quarterly
reports on Form 10-Q. Any forward-looking statement made by the
Company in this release speaks only as of the date on which it is
made. The Company undertakes no obligation to publicly update any
forward-looking statement, whether as a result of new information,
future developments or otherwise, except as may be required by any
applicable securities laws.
FOR MORE INFORMATION, PLEASE CONTACT:
Investor
Relations
Asher Dewhurst
investors@apollomed.net
View original content to download
multimedia:https://www.prnewswire.com/news-releases/apollo-medical-holdings-inc-announces-leadership-transitions-302042938.html
SOURCE Apollo Medical Holdings, Inc.